Tetrahydrofuran → HCID 22063804, compound
Reaction equation
[CH2:1]([N:3]1[C:7]2[CH:8]=[CH:9][C:10]([C:12]3[NH:13][C:14]([C:24](F)(F)F)=[N:15][C:16]=3[C:17]3[CH:18]=[C:19]([CH3:23])[CH:20]=[CH:21][CH:22]=3)=[CH:11][C:6]=2[N:5]([CH3:28])[C:4]1=[O:29])[CH3:2].CCN=C=NCCCN(C)C.[NH:41]1[CH2:46][CH2:45][O:44][CH2:43][CH2:42]1.C1C[O:50]CC1>CN(C=O)C>[CH2:1]([N:3]1[C:7]2[CH:8]=[CH:9][C:10]([C:12]3[NH:13][C:14]([C:24]([N:41]4[CH2:46][CH2:45][O:44][CH2:43][CH2:42]4)=[O:50])=[N:15][C:16]=3[C:17]3[CH:18]=[C:19]([CH3:23])[CH:20]=[CH:21][CH:22]=3)=[CH:11][C:6]=2[N:5]([CH3:28])[C:4]1=[O:29])[CH3:2]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
A mixture of 1-ethyl-3-methyl-5-(5-m-tolyl-2-trifluoromethyl-3H-imidazol-4-yl)-1,3-dihydro-benzoimidazol-2-one (prepared as described above, 50 mg, 0.13 mmol), N,N-dimethylaminopyridine (48.7 mg, 0.40 mmol), EDCI (38.3 mg, 0.20 mmol) and morpholine (17.4 mg, 0.20 mmol) was stirred at room temperature in THF (1.33 mL) at room temperature. One drop of DMF was added to ensure solubility. The reaction mixture was allowed to stir overnight. The mixture was concentrated in vacuo, taken up in methylene chloride and washed with 10% aqueous citric acid. The organic phase was dried over anhydrous sodium sulfate and concentrated in vacuo to afford a reddish-brown solid, which was recrystallized in diisopropyl ether to give 19 mg of the title compound. MS (M+1)=446.5.
Workup
- concentrationThe mixture was concentrated in vacuo
- washwashed with 10% aqueous citric acid
- dry with materialThe organic phase was dried over anhydrous sodium sulfate
- concentrationconcentrated in vacuo
- customto afford a reddish-brown solid, which
- customwas recrystallized in diisopropyl ether
Sources & evidence
- ORD record
- ord-f33bed92781240afb07925a94bdfafe7
- Source dataset
- uspto-grants-2006_06
- Patent number
- US07056918B2
Reaction notes
Loading…